Feriani Mariano, Passlick-Deetjen Jutta, Jaeckle-Meyer Irmtrud, La Greca Giuseppe
Department of Dialysis and Nephrology, Vicenza, Italy.
Nephrol Dial Transplant. 2004 Jan;19(1):195-202. doi: 10.1093/ndt/gfg472.
A large percentage of peritoneal dialysis (PD) patients being treated with standard lactate-containing solutions tend to have serum bicarbonate concentrations below or above the normal range. The inter-patient variability of serum bicarbonate is a result of many influences and it may be appropriate to adjust the bicarbonate concentration in the peritoneal dialysis fluid (PDF) to the current serum bicarbonate in the individual patient.
Two concentrations of bicarbonate in PDF were compared in this study (34 and 39 mmol/l). Eligible patients underwent a pre-study phase of 12 weeks to determine serum bicarbonate every six weeks. Sixty-one patients entered the stratification phase. Acidotic patients (serum venous bicarbonate <25.3 mmol/l) were allocated to the high bicarbonate solution, patients in the normal serum bicarbonate range or alkalotic patients (serum venous bicarbonate >25.3 mmol/l) to the low bicarbonate solution. Patients were followed up for 24 weeks, in which study visits were performed every 6 weeks to assess acid-base status, peritoneal and renal function, and to calculate protein nitrogen appearance rate (PNA).
Patients with acidosis at baseline had higher body weight, body surface area, blood urea nitrogen, serum creatinine and PNA than patients with bicarbonate within the normal range or with alkalosis. They significantly improved their serum bicarbonate (23.45 +/- 2.5 vs 25.7 +/- 2.8 mmol/l, baseline vs week 24; P < 0.01), whereas patients treated with the low bicarbonate PDF maintained their serum venous bicarbonate over the 24 week study period (27.77 +/- 2.9 vs 27.06 +/- 2.1 mmol/l, baseline vs week 24; P = NS). Analysing both study groups together, at baseline, 66% of the patients presented with mild to moderate acidosis, this figure at the end of the study was 23.4%. PNA did not change in the two groups; however, in the subgroup of patients (N = 23) in whom the 39 mmol/l PDF was effective in correcting metabolic acidosis, a decrease in PNA was observed.
The study demonstrated that the individualized application of low and high bicarbonate PD PDFs allows one to achieve normal acid-base status in a large percentage of CAPD patients with potential benefits to nutritional status.
接受标准含乳酸盐溶液治疗的大量腹膜透析(PD)患者的血清碳酸氢盐浓度往往低于或高于正常范围。血清碳酸氢盐在患者间的变异性是多种因素影响的结果,根据个体患者当前的血清碳酸氢盐浓度调整腹膜透析液(PDF)中的碳酸氢盐浓度可能是合适的。
本研究比较了PDF中两种碳酸氢盐浓度(34和39mmol/L)。符合条件的患者进行为期12周的研究前期,每六周测定血清碳酸氢盐。61名患者进入分层阶段。酸中毒患者(血清静脉碳酸氢盐<25.3mmol/L)被分配至高碳酸氢盐溶液组,血清碳酸氢盐在正常范围内的患者或碱中毒患者(血清静脉碳酸氢盐>25.3mmol/L)被分配至低碳酸氢盐溶液组。对患者进行24周的随访,在此期间每6周进行一次研究访视,以评估酸碱状态、腹膜和肾功能,并计算蛋白质氮出现率(PNA)。
基线时酸中毒患者的体重、体表面积、血尿素氮、血清肌酐和PNA高于血清碳酸氢盐在正常范围内或碱中毒的患者。他们的血清碳酸氢盐显著改善(基线时为23.45±2.5mmol/L,第24周时为25.7±2.8mmol/L;P<0.01),而接受低碳酸氢盐PDF治疗的患者在24周的研究期间维持其血清静脉碳酸氢盐水平(基线时为27.77±2.9mmol/L,第24周时为27.06±2.1mmol/L;P=无显著性差异)。将两个研究组一起分析,基线时,66%的患者表现为轻度至中度酸中毒,研究结束时这一数字为23.4%。两组的PNA均未改变;然而,在39mmol/L的PDF有效纠正代谢性酸中毒的患者亚组(N=23)中,观察到PNA下降。
该研究表明,个体化应用低和高碳酸氢盐PD PDFs可使大部分持续性非卧床腹膜透析(CAPD)患者实现正常酸碱状态,对营养状况可能有益。